Investors buy biotechs on news of merger
Article Abstract:
Upon hearing the announcement about the merger of Shire Pharmaceuticals Group PLC with BioChem Pharma Inc., investors bid up shares of biotechnology companies. The Toronto Stock Exchange index for biotechnology and pharmaceuticals rose several points. Company shares that may benefit from the uptrend are those of Biovail Corp., Angiotech Pharamaceuticals Inc. and QLT Inc.
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Ottawa approves biotech deal as probe launched
Article Abstract:
Shire Pharmaceutical Group PLC's planned merger with BioChem Pharma Inc. has been approved by Investment Canada. The deal is valued at 5.9 billion Canadian dollars. In addition, the London Stock Exchange has launched a probe into the trading of Shire's stock.
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
BioChem in blockbuster merger with Shire PLC
Article Abstract:
BioChem Pharma Inc., a Canadian biotech company announced it would merge with Shire Pharmaceuticals Group PLC of Britain. BioChem receives $200 million a year in royalties from Glaxo Wellcome PLC which markets 3TC, an Aids drug and Zeffix.
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Media powerhouses buy into new world order. AOL Time Warner receives tepid response to plans
- Abstracts: FCC to make a call on phone deal. SBC-Ameritech deal may face conditions
- Abstracts: Descartes buys BCE Energis service. Delano buys U.S.-based Digital for $87-million. MGI strikes deal to be bought
- Abstracts: No toasts as Seagram investors bless deal. Seagram eyes Canadian approval. Diageo, Pernod buy Seagram drinks group for $8.15-billion
- Abstracts: National Bank seeks pill approval. National CEO resolute on merger plans. National Bank posts 7% profit increase in 4th quarter